NYSE Updates Psychedelic drug contender stocks drop after FDA rejects MDMA treatment By Admin August 12, 2024 0 19 Share FacebookTwitterPinterestWhatsApp Must read Russia-Ukraine war: List of key events, day 939 | Russia-Ukraine war News September 21, 2024 Just Another Frivolous Climate Lawsuit – Watts Up With That? September 21, 2024 Where NFL, CFB stars in this weekend’s spotlight were ranked in HS September 21, 2024 Boeing defence head exits in first executive change under new CEO September 21, 2024 Adminhttps://newschatspot.com Shares of companies developing treatments based on psilocybin and other psychedelic drugs moved lower on Monday after the U.S. Food and Drug Administration rejected use of MDMA for post-traumatic stress disorder. Share FacebookTwitterPinterestWhatsApp Previous articleRachel Fuda: PREGNANT with Child #4!!!!!!!Next articleCarlos Alcaraz addresses getting 2nd match of the day for QF against Tommy Paul after playing doubles with Rafael Nadal the night before More articles Honduras top court declares self-governing ZEDE zones unconstitutional By Reuters September 21, 2024 Nike’s stock has been dogged by these issues. Can a new CEO change the game? September 20, 2024 FedEx stock target cut on demand concerns, retains buy rating By Investing.com September 20, 2024 LEAVE A REPLY Cancel reply Comment: Please enter your comment! Name:* Please enter your name here Email:* You have entered an incorrect email address! Please enter your email address here Website: Save my name, email, and website in this browser for the next time I comment. Latest article Russia-Ukraine war: List of key events, day 939 | Russia-Ukraine war News September 21, 2024 Just Another Frivolous Climate Lawsuit – Watts Up With That? September 21, 2024 Where NFL, CFB stars in this weekend’s spotlight were ranked in HS September 21, 2024 Boeing defence head exits in first executive change under new CEO September 21, 2024 Cheryl Hines’ Divorce and Marriage History With RFK Jr., Explained September 21, 2024